ICSSUi004-A

General

Cell Line

hPSCreg name ICSSUi004-A
Cite as:
ICSSUi004-A (RRID:CVCL_D6NU)
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
FAMRCi009-A
(RCMP43)
Donor's gene variants:
FLNC
Donor diseases:
Restrictive Cardiomyopathy
PUMCHi002-A
(20180908R-AE3, PUMCH-IRC)
Donor diseases:
Restrictive Cardiomyopathy
FAMRCi010-A
(RCMP48)
Donor's gene variants:
FLNC
Donor diseases:
Restrictive Cardiomyopathy
CIRMi04U-A
(CW30484)
Donor diseases:
Restrictive Cardiomyopathy
SCVIi037-A
(SCVI672)
Donor diseases:
hypertrophic cardiomyopathy
ITXi003-A
(MS368)
Donor diseases:
Long QT Syndrome
UKKi035-A
(NP0139-A, NP0139-3E)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi035-B
(NP0139-B, NP0139-6C)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi035-C
(NP0139-C, NP0139-24D)
Donor's gene variants:
MYBPC3, MYBPC3
Donor diseases:
Rare hypertrophic cardiomyopathy
FAMRCi011-A
(ARVC51)
Donor's gene variants:
FLNC
Donor diseases:
Inherited arrhythmogenic cardiomyopathy
YCMi009-A
(YCMi009-hDCM009-A)
Donor diseases:
dilated cardiomyopathy
ICGi028-A
(HCM4fm5.2)
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi005-A
(F81 (940) clone 5)
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi005-B
(F81 (940) clone 8)
Donor diseases:
Hypertrophic Cardiomyopathy
FAMRCi011-B
(ARVC51b)
Donor's gene variants:
FLNC
Donor diseases:
Inherited arrhythmogenic cardiomyopathy
IBBISTi007-A
(6F26)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi007-B
(2F26)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi096-A
(SCVI-675fs1)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi097-A
(SCVI-675fs2)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi098-A
(SCVI-675fs3)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi099-A
(SCVI-675fs4)
Donor diseases:
Hypertrophic Cardiomyopathy
CCMi012-A
(LMNA_SP_C3)
Donor diseases:
Dilated Cardiomyopathy
SCVIi050-A
(SCVI2486)
Donor diseases:
Dilated Cardiomyopathy
SCVIi073-A
(SCVIi574C2)
Donor's gene variants:
titin, BAG cochaperone 3, BAG cochaperone 3
Donor diseases:
Dilated Cardiomyopathy
SCVIi061-A
(SCVI2149C1)
Donor diseases:
Long QT Syndrome
SCVIi074-A
(SCVIi599C1)
Donor's gene variants:
BAG cochaperone 3
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi062-A
(SCVI2150c1)
Donor diseases:
Long QT Syndrome
ITXi004-A
(MS381)
Donor diseases:
Long QT Syndrome
FAMRCi006-A
(LMNA T3)
Donor's gene variants:
LMNA
Donor diseases:
Emery-Dreifuss Muscular Dystrophy
Dilated Cardiomyopathy
FAMRCi006-B
(LMNA T4)
Donor's gene variants:
LMNA
Donor diseases:
Emery-Dreifuss Muscular Dystrophy
Dilated Cardiomyopathy
UKKi031-A
(NP0138-8B)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi031-B
(NP0138-19E)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi031-C
(NP0138-31B)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
Last update 7th February 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Institute for Cardiovascular Science of Soochow University (ICSSU)

External Databases

BioSamples SAMEA115064445
Cellosaurus CVCL_D6NU

General Information

Publications
* Is the cell line readily obtainable for third parties?
No

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Synonyms
  • Restrictive Cardiomyopathy
  • Restrictive cardiomyopathy

External Databases (Donor)

BioSamples SAMEA115064446

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Alternatives to consent are available? No
Is there other documentation provided to the donor for consenting purposes? No
Confirm that consent was obtained by a qualified professional Yes
Has the donor agreed to be re-contacted? Unknown
Has the donor been informed about how her/his data will be protected? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? No
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent expressly permit storage of donated embryo/tissue for an unlimited time? No
Does consent expressly permit storage of cells derived from the donated embryo/tissue for an unlimited time? No
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? No information
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Ethics Committee of First Affiliated Hospital of Soochow University
Approval number No. 2017-264
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
Synonyms
  • Peripheral blood monocyte

Reprogramming method

Vector type Integrating
Vector Virus (Lentivirus)
Is the used vector excisable?
Unknown
Absence of reprogramming vector(s)?
Unknown
Reprogramming vectors silenced?

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Essential 8™

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1
Yes
SOX2
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Marker Expressed
SOX17
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Marker Expressed
ACTA2
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation
Marker Expressed
TUBB3
Yes

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46 XY

Other Genotyping (Cell Line)